{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:44:36Z","timestamp":1791945876694,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.parkreldis.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T11:42:57Z","timestamp":1603280577000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Parkinsonism in children: Clinical classification and etiological spectrum"],"prefix":"10.1016","volume":"82","author":[{"given":"Vincenzo","family":"Leuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nardecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Galosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2020.10.002_bib1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/11533130-000000000-00000","article-title":"Juvenile parkinsonism: epidemiology, diagnosis and treatment","volume":"24","author":"Thomsen","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib4","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s007020200095","article-title":"Mini-review: multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism","volume":"109","author":"Riederer","year":"2002","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.06.025","article-title":"Juvenile parkinsonism: differential diagnosis, genetics, and treatment","author":"Niemann","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib6","article-title":"Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence","author":"Morales-Brice\u00f1o","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"Blau","year":"2010","journal-title":"Phenylketonuria, Lancet"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib8","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/ana.10632","article-title":"Tyrosine hydroxylase deficiency causes progressive encephalopathy and Dopa-nonresponsive dystonia","volume":"54","author":"Hoffmann","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency","volume":"12","author":"Wassenberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/mdc3.12897","article-title":"Treatable inherited movement disorders in children: spotlight on clinical and biochemical features","volume":"7","author":"Galosi","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mds.20699","article-title":"Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"21","author":"Roze","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.22685","article-title":"Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy","volume":"71","author":"Friedman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib13","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1212\/01.wnl.0000437299.51312.5f","article-title":"Very early pattern of movement disorders in sepiapterin reductase deficiency","volume":"81","author":"Leuzzi","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","article-title":"Monoamine neurotransmitter disorders - clinical advances and future perspectives","volume":"11","author":"Ng","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/hmg\/5.7.1023","article-title":"Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene","volume":"5","author":"L\u00fcdecke","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib16","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awq087","article-title":"Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis","volume":"133","author":"Willemsen","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib17","first-page":"39","article-title":"Report of two never treated adult sisters with aromatic l-amino acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?","volume":"15","author":"Leuzzi","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.10095","article-title":"Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy","volume":"17","author":"Grattan-Smith","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib19","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1212\/WNL.0b013e3182452849","article-title":"Child Neurology: paroxysmal stiffening, upward gaze, and hypotonia. Hallmarks of sepiapterin reductase deficiency","volume":"78","author":"Dill","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2016.11.012","article-title":"Oculogyric crises: etiology, pathophysiology and therapeutic approaches","volume":"36","author":"Barow","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-991151","article-title":"Tyrosine hydroxylase deficiency presenting with a biphasic clinical course","volume":"38","author":"Glovanniello","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1399-0004.2009.01306.x","article-title":"Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"77","author":"Leuzzi","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s004310000722","article-title":"Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"160","author":"Dude\u0161ek","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.65.3.387","article-title":"Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"65","author":"Liu","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/WNL.0000000000003539","article-title":"Neuromotor and cognitive outcomes of early treatment in tyrosine hydroxylase deficiency type b","volume":"88","author":"Leuzzi","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2019.03.009","article-title":"Aromatic amino acid decarboxylase deficiency: molecular and metabolic basis and therapeutic outlook","volume":"127","author":"Himmelreich","year":"2019","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib27","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1212\/01.WNL.0000126440.16612.51","article-title":"Infantile parkinsonism-dystonia and elevated dopamine metabolites in CSF","volume":"62","author":"Assmann","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","article-title":"Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awu022","article-title":"Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood","volume":"137","author":"Ng","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/cge.13172","article-title":"Biallelic mutations in mitochondrial tryptophanyl-tRNA synthetase cause Levodopa-responsive infantile-onset Parkinsonism","volume":"93","author":"Burke","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/0883073819854604","article-title":"Expanding the phenotype: neurodevelopmental disorder, mitochondrial., with abnormal movements and lactic acidosis, with or without seizures (NEMMLAS) due to WARS2 biallelic variants, encoding mitochondrial tryptophanyl-tRNA synthase","volume":"34","author":"Virdee","year":"2019","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/EBC20170103","article-title":"Mitochondrial DNA transcription and translation: clinical syndromes","volume":"62","author":"Boczonadi","year":"2018","journal-title":"Essays Biochem."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature20414","article-title":"Defects in trafficking bridge Parkinson's disease pathology and genetics","volume":"539","author":"Abeliovich","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1089071","article-title":"Postnatal neurodevelopmental disorders: meeting at the synapse?","volume":"302","author":"Zoghbi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib37","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nn.4420","article-title":"Lessons learned from studying syndromic autism spectrum disorders","volume":"19","author":"Sztainberg","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/WNL.40.2.293","article-title":"Extrapyramidal involvement in Rett's syndrome","volume":"40","author":"FitzGerald","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mds.21276","article-title":"Rett syndrome: an overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, Parkinsonism, and dystonia?","volume":"22","author":"Roze","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/cjn.2016.8","article-title":"The incidence and evolution of parkinsonian rigidity in Rett syndrome: a pilot study","volume":"43","author":"Humphreys","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.wnl.0000259086.34769.78","article-title":"Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations","volume":"68","author":"Temudo","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mdc3.12865","article-title":"Parkinsonism, intellectual disability, and catatonia in a young male with MECP2 variant","volume":"7","author":"Pollini","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/ccr3.2260","article-title":"Heterozygous loss of function of NR4A2 is associated with intellectual deficiency, rolandic epilepsy, and language impairment","volume":"7","author":"Ramos","year":"2019","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27982","article-title":"Loss-of-function mutations in NR4A2 cause dopa-responsive dystonia Parkinsonism","author":"Wirth","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib46","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1212\/WNL.0000000000000521","article-title":"Anterocollis and levodopa-responsive parkinsonism are late features of dravet syndrome","volume":"82","author":"Fasano","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","article-title":"Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with \u03b1-synuclein pathology","volume":"95","author":"Wilson","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.parkreldis.2018.10.012","article-title":"Neurotransmitter trafficking defect in a patient with clathrin (CLTC) variation presenting with intellectual disability and early-onset parkinsonism","volume":"61","author":"Manti","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng.2562","article-title":"De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood","volume":"45","author":"Saitsu","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2017.09.014","article-title":"Expanding the phenotype of SCA19\/22: parkinsonism, cognitive impairment and epilepsy, Park","volume":"45","author":"Huin","year":"2017","journal-title":"Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib51","series-title":"Cerebellar Ataxia, Myoclonus, and Dystonia, Cerebellum","article-title":"Novel de novo KCND3 mutation in a Japanese patient with intellectual disability","author":"Kurihara","year":"2018"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib52","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.27501","article-title":"PTRHD1 Loss\u2010of\u2010function mutation in an african family with juvenile\u2010onset Parkinsonism and intellectual disability","volume":"33","author":"Kuipers","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib53","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"L\u00fccking","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.20256","article-title":"PINK1 mutations are associated with sporadic early-onset Parkinsonism","volume":"56","author":"Valente","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib55","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(08)70022-X","article-title":"DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA","volume":"7","author":"Camargos","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036458","article-title":"A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating Co-chaperone auxilin, is associated with juvenile parkinsonism","volume":"7","author":"Edvardson","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.parkreldis.2020.10.002_bib58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","volume":"19","author":"K\u00f6ro\u011dlu","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","article-title":"DNAJC6 mutations associated with early-onset Parkinson's disease","volume":"79","author":"Olgiati","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib60","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.25048","article-title":"DNAJC12 and dopa-responsive nonprogressive parkinsonism","volume":"82","author":"Straniero","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib61","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/mds.27801","article-title":"Revising rapid-onset dystonia\u2013parkinsonism: broadening indications for ATP1A3 testing","volume":"34","author":"Haq","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib62","first-page":"1814","article-title":"Clinical spectrum of secondary Parkinsonism in childhood: a reversible disorder","volume":"33","author":"Pranzatelli","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib63","first-page":"5483","article-title":"Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance","volume":"25","author":"Lubbe","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2020.10.002_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2020.02.003","article-title":"Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism","author":"Martinelli","year":"2020","journal-title":"Park. Relat. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202030777X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202030777X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:50Z","timestamp":1761178910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202030777X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":64,"alternative-id":["S135380202030777X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.10.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinsonism in children: Clinical classification and etiological spectrum","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}